Michael Martin Breen - Jul 15, 2022 Form 4 Insider Report for GT Biopharma, Inc. (GTBP)

Role
Exec. Chair. and Interim CEO, Director
Signature
/s/ Michael Martin Breen
Stock symbol
GTBP
Transactions as of
Jul 15, 2022
Transactions value $
$0
Form type
4
Date filed
7/19/2022, 09:48 PM
Previous filing
Nov 12, 2021
Next filing
Feb 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GTBP Common Stock Award $0 +278K +84.73% $0.00 606K Jul 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GTBP Option to purchase Common Stock Award $0 +50K $0.00 50K Jul 15, 2022 Common Stock 50K $2.48 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.